BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15255421)

  • 1. Prevention of glucocorticoid-induced osteoporosis.
    Saag KG
    South Med J; 2004 Jun; 97(6):555-8. PubMed ID: 15255421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-induced osteoporosis: treatment options and guidelines.
    Maricic M
    Curr Osteoporos Rep; 2005 Mar; 3(1):25-9. PubMed ID: 16036098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.
    Orcel P
    Joint Bone Spine; 2005 Dec; 72(6):461-5. PubMed ID: 16326129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroenterologists and choosing the right bisphosphonate.
    Leder BZ; Kronenberg HM
    Gastroenterology; 2000 Sep; 119(3):866-9. PubMed ID: 10982780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Randomized controlled trials for the prevention and treatment of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2006 Nov; 16(11):1834-42. PubMed ID: 17079850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
    Sato S
    Clin Calcium; 2007 Apr; 17(4):600-5. PubMed ID: 17404491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to prevent glucocorticoid-induced osteoporosis.
    Bachmeyer C; Gauthier M
    Cleve Clin J Med; 2010 Nov; 77(11):762; author reply 762. PubMed ID: 21086710
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.
    Cowan S; Morin S; Ernst P
    Thorax; 1998 May; 53(5):331-2. PubMed ID: 9708219
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous zoledronic acid: what are the indications for male osteoporosis?
    Maricic M
    Curr Osteoporos Rep; 2010 Mar; 8(1):4-9. PubMed ID: 20425084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of alendronate and risedronate in preventing and treating osteoporosis.
    Peters ML; Leonard M; Licata AA
    Cleve Clin J Med; 2001 Nov; 68(11):945-51. PubMed ID: 11718433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of osteoporosis for people over 70.
    Moro Alvarez MJ; Díaz-Curiel M
    Aging Clin Exp Res; 2007 Jun; 19(3):246-54. PubMed ID: 17607094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture prevention in postmenopausal women.
    Mosekilde L; Vestergaard P; Langdahl B
    Clin Evid; 2006 Jun; (15):1543-60. PubMed ID: 16973058
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guide for the prevention and treatment of glucocorticoid-induced osteoporosis of the Spanish Society of Internal Medicine].
    Sosa Henríquez M; Díaz Curiel M; Díez Pérez A; Gómez Alonso C; González Macías J; Farrerons Minguella J; Filgueira Rubio J; Mellibovsky Saidler L; Nogués Solán X; Hernández Hernández D;
    Rev Clin Esp; 2008 Jan; 208(1):33-45. PubMed ID: 18221660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: hope on the HORIZON.
    Gennari L; Bilezikian JP
    Lancet; 2009 Apr; 373(9671):1225-6. PubMed ID: 19362657
    [No Abstract]   [Full Text] [Related]  

  • 15. Parathyroid hormone.
    Madore GR; Sherman PJ; Lane JM
    J Am Acad Orthop Surg; 2004; 12(2):67-71. PubMed ID: 15089079
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention and treatment of glucocorticoid-induced osteoporosis.
    Curtis JR; Saag KG
    Curr Osteoporos Rep; 2007 Mar; 5(1):14-21. PubMed ID: 17320023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM; Valeriano J; Vasey FB; Carter JD
    J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis in men.
    Geier KA
    Orthop Nurs; 2001; 20(6):49-56. PubMed ID: 12025803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
    Trémollières F
    Gynecol Obstet Fertil; 2001 Nov; 29(11):846-52. PubMed ID: 11770280
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates: new indications and methods of administration.
    Reid IR
    Curr Opin Rheumatol; 2003 Jul; 15(4):458-63. PubMed ID: 12819475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.